Organization | Pan American Health Organization

Pan American Health Organization Report issue

Government Phase 2 Phase 3 Phase 4

Founded: Washington D.C. United States (1902)

Organization Overview

First Clinical Trial

1999

NCT02386358

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Alba Maria Ropero | Pan American Health Organization

Active Ingredients

Drugs in Phase 4 Trials (4)

chloroquine (2 trials)

measles, mumps, and rubella vaccine (MMR) (1 trial)

primaquine (2 trials)

yellow fever vaccine 17d strain (1 trial)

Drugs in Phase 3 Trials (3)

artesunate (1 trial)

benznidazole (Rochagan) (1 trial)

mefloquine (lariam) (1 trial)

Drugs in Phase 2 Trials (1)

inactivated influenza vaccine (1 trial)

Drugs in Other Trials (2)

polio, inactivated poliovirus vaccine (Salk Vaccine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Chagas Disease (Phase 3)

Influenza, Human (Phase 2)

Malaria (Phase 4)

Malaria, Falciparum (Phase 3)

Malaria, Vivax (Phase 4)

Rubella (Phase 4)

Yellow Fever (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 9
# of Trial APIs: 10